NewcelX Ltd. NCEL
2.89 USD +0.09 (+3.21%)
Nov 12, 2026, 12:20 PM EST
2.82 Day range 2.98
1.83 52-week range 5.12
- YTD
- +52.10%
- 1 year
- -21.47%
- Market cap
- 16.69M
- EPS (ttm)
- 0.52
- P/E ratio
- 5.56
- YTD return
- +52.10%
- 1-year return
- -21.47%
- Volume
- 4.80K
- Avg volume
- 13.94K
- Open
- 2.92
- Previous close
- 2.80
- Day's range
- 2.82 – 2.98
- 52-week range
- 1.83 – 5.12
5D +0.38 (+15.83%)
Financials — quick view
NCEL Revenue — annual 0
NCEL Net income — annual -8.30M
NCEL EPS — annual -2.16
News
CORRECTION: NewcelX Announces $1.55M Private Placement Of 471,125 Common Shares And One Series Of Warrants At A Price Of $3.29 Per Share 
NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market 
12 Health Care Stocks Moving In Friday's Pre-Market Session 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
12 Health Care Stocks Moving In Thursday's Pre-Market Session - 12 Health Care Stocks Moving In Friday's Pre-Market Session
NewcelX Issued Patent From Brazilian Patent And Trademark Office For Its Nnovative Cell Selection And Enrichment Technology 
Laidlaw & Co. Initiates Coverage On NewcelX with Buy Rating, Announces Price Target of $23 
NewcelX Completes Type B Pre-IND Meeting With FDA; Administration Provided Constructive Feedback And Alignment On Proposed Strategy - NewcelX Announces Publication Of Peer-Reviewed Study On The Potential Of AstroRx, A Human Embryonic Stem Cells-Derived Astrocyte Therapy, In The Journal Stem Cell Reports
Your note
Sign in to keep a note on NCEL — it syncs with the Stock Master app.